Viewing Study NCT06070961


Ignite Creation Date: 2025-12-24 @ 12:17 PM
Ignite Modification Date: 2026-01-26 @ 1:34 AM
Study NCT ID: NCT06070961
Status: RECRUITING
Last Update Posted: 2025-06-29
First Post: 2023-10-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance
Sponsor: Fondazione Italiana Linfomi - ETS
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: FIL_FollVax 22
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators